Literature DB >> 9373845

Postnatal inositol levels in preterm infants.

J D Carver1, C I Stromquist, V J Benford, G Minervini, S A Benford, L A Barness.   

Abstract

OBJECTIVE: To measure plasma inositol levels in preterm infants fed formula containing inositol at levels close to those in human milk. STUDY
DESIGN: Plasma inositol levels were measured in 72 preterm infants fed formula containing 1110 mumol/L inositol and in cord blood of 12 healthy term infants. Preterm infant plasma levels were measured four times: (1) within the first 7 days of life, (2) intermediate enteral feeding, (3) at hospital discharge, and (4) 2 months after hospital discharge.
RESULTS: Inositol concentrations in term cord blood samples were significantly lower than in preterm initial feeding, intermediate feeding, and discharge samples. Initial concentrations in blood of preterm infants were higher than in all other groups, and were significantly lower among infants with gestational ages of 31 to 33 weeks compared with those of 28 to 30 or 31 to 33 weeks. Days of parenteral nutrition were a significant predictor of inositol levels in the full feeding sample, with lower levels associated with prolonged parenteral nutrition. Clinical outcomes were not related to plasma inositol levels.
CONCLUSIONS: Feeding preterm formula with inositol levels close to those reported for human milk may not prevent the postnatal decline in preterm infant plasma inositol levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373845

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  8 in total

Review 1.  The management of retinopathy of prematurity.

Authors:  J D Reynolds
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Quantification of myo-inositol, 1,5-anhydro- D-sorbitol, and D-chiro-inositol using high-performance liquid chromatography with electrochemical detection in very small volume clinical samples.

Authors:  Karen J Schimpf; Claudia C Meek; Richard D Leff; Dale L Phelps; Daniel J Schmitz; Christopher T Cordle
Journal:  Biomed Chromatogr       Date:  2015-05-26       Impact factor: 1.902

3.  Nutrition, insulin-like growth factor-1 and retinopathy of prematurity.

Authors:  Anna-Lena Hård; Lois E Smith; Ann Hellström
Journal:  Semin Fetal Neonatal Med       Date:  2013-02-18       Impact factor: 3.926

4.  Inositol and mannose utilization rates in term and late-preterm infants exceed nutritional intakes.

Authors:  Laura D Brown; Alex Cheung; Jeri E F Harwood; Frederick C Battaglia
Journal:  J Nutr       Date:  2009-06-03       Impact factor: 4.798

5.  Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk.

Authors:  Dale L Phelps; Robert M Ward; Rick L Williams; Kristi L Watterberg; Abbot R Laptook; Lisa A Wrage; Tracy L Nolen; Timothy R Fennell; Richard A Ehrenkranz; Brenda B Poindexter; C Michael Cotten; Mikko K Hallman; Ivan D Frantz; Roger G Faix; Kristin M Zaterka-Baxter; Abhik Das; M Bethany Ball; T Michael O'Shea; Conra Backstrom Lacy; Michele C Walsh; Seetha Shankaran; Pablo J Sánchez; Edward F Bell; Rosemary D Higgins
Journal:  Pediatr Res       Date:  2013-09-04       Impact factor: 3.756

Review 6.  Excess iron intake as a factor in growth, infections, and development of infants and young children.

Authors:  Bo Lönnerdal
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

7.  Blood myo-inositol concentrations in preterm and term infants.

Authors:  Luc P Brion; Dale L Phelps; Robert M Ward; Tracy L Nolen; N Mikko K Hallman; Abhik Das; Daniel J Zaccaro; M Bethany Ball; Kristi L Watterberg; Ivan D Frantz; C Michael Cotten; Brenda B Poindexter; William Oh; Ralph A Lugo; Krisa P Van Meurs; T Michael O'Shea; Kristin M Zaterka-Baxter; Rosemary D Higgins
Journal:  J Perinatol       Date:  2020-09-15       Impact factor: 2.521

8.  Inositol Analysis by HPLC and Its Stability in Scavenged Sample Conditions.

Authors:  Robert M Ward; John Sweeley; Ralph A Lugo
Journal:  Med Chem (Los Angeles)       Date:  2015-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.